Change in the position of CEO of Medtronic Poland

According to Medtronic Poland sp.z o.o., on June 1, 2022, Anna Sadowska-Segit took the position of CEO of the company. She replaced Adam Jagoda, who after 20 years at the Polish branch of Medtronic, took the position of Business Development Director Surgical Innovations (SI) in the Asia-Pacific region (APAC) at Medtronic.

Anna Sadowska-Segit began her career at Johnson & Johnson (1995 - 2002). She has been with Medtronic for 10 years. She joined the Diabetes team, which she developed as the Country Business Manager of Diabetes Poland, and later as the Business Director of Diabetes in the Central and Eastern Europe (CEE) region. In the last 2 years, she was the Strategic Market Enterprise Diabetes Director in the Central and Eastern Europe, Middle East and Africa (CEMA) region. Anna Sadowska-Segit is a graduate of the Medical University of Lublin (Faculty of Medicine) and postgraduate studies at the Lublin Business School and Collegium Medicum of the Jagiellonian University.

Source: Medtronic